Characterization, monitoring and management of interstitial lung disease in patients with metastatic breast cancer: Analysis of data available from multiple studies of DS-8201a, a HER2-targeted antibody drug conjugate with a topoisomerase I inhibitor payload Meeting Abstract
| Authors: | Powell, C. A.; Camidge, D. R.; Gemma, A.; Kusumoto, M.; Baba, T.; Kuwano, K.; Bankier, A.; Kiura, K.; Tamura, K.; Modi, S.; Tsurutani, J.; Doi, T.; Iwata, H.; Krop, I. E.; Zhang, L.; Jasmeet, S.; Saito, K.; Shahidi, J.; Yver, A.; Takahashi, S. |
| Abstract Title: | Characterization, monitoring and management of interstitial lung disease in patients with metastatic breast cancer: Analysis of data available from multiple studies of DS-8201a, a HER2-targeted antibody drug conjugate with a topoisomerase I inhibitor payload |
| Meeting Title: | 41st Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Dec 4-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000478677002274 |
| DOI: | 10.1158/1538-7445.Sabcs18-p6-17-06 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P6-17-06 -- Source: Wos |
